WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

iDexis rejects Sahpra claims in weight‑loss drug recall order

Local firm iDexis says it can guarantee quality and safety of its GLP-1 jabs

Raccontata dabusinessday.co.zaiol.co.za

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
businessday.co.zaStai leggendo17 h fa

iDexis rejects Sahpra claims in weight‑loss drug recall order

Local firm iDexis says it can guarantee quality and safety of its GLP-1 jabs

originale
iol.co.za1 g fa

Pharmacy ordered to recall unregistered weight-loss medicines after raid

THE South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have launched a crackdown on the illegal manufacturing and distribution of unregistered weight-loss medicines…

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 25 maggio 2026·businessday.co.za

    Regulator cracks down on illegal weight-loss drugs as demand booms

    Sahpra's crackdown comes amid booming global demand for GLP-1 therapies

  2. lunedì 25 maggio 2026·iol.co.za

    Pharmacy ordered to recall unregistered weight-loss medicines after raid

    THE South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have launched a crackdown on the illegal manufacturing and…

  3. martedì 26 maggio 2026·businessday.co.za

    iDexis rejects Sahpra claims in weight‑loss drug recall order

    Local firm iDexis says it can guarantee quality and safety of its GLP-1 jabs